REUTERS/Kathleen Flynn
(Reuters) -Danaher Corp said on Wednesday it would separate its environmental & applied solutions (EAS) segment to pivot growth towards the medical technology firm's life sciences and diagnostics businesses.
Danaher insider Jennifer Honeycutt, who joined the company in 1999, will become the president and chief executive officer of the new publicly traded company after the transaction closes in the fourth quarter of 2023.
Already a subscriber? Log in.
Unlock 30% Savings on Ad-Free Access Now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
